Multicenter phase II trial of dose-fractionated irinotecan in patients with advanced colorectal cancer failing oxaliplatin-based first-line combination chemotherapy.
暂无分享,去创建一个
W. Scheithauer | M. Raderer | G. Kornek | D. Depisch | H. Ulrich-Pur | W. Fiebiger | J. Pidlich | A. Lenauer | F. Lang | C. Gedlicka | H. Ulrich‐Pur